Why Stem Stock Fell 13% Today

Stem Inc. fell 13% in regular trading hours after its board began a formal review of strategic options. The review includes possible sales and financing changes, but Stem named no buyer, agreed terms, or preferred path. That uncertainty leaves shareholders without an actual offer or outcome to weigh against the plan to continue on its own.

What Stem Inc. Does

Stem provides software and services that help clean-energy asset owners monitor and improve their operations. PowerTrack is its software for monitoring and optimizing energy assets.

Stem Strategic Review Options

The board is weighing continued independence, asset or company sales, a merger, refinancing, recapitalization, and other paths. A merger combines companies; refinancing replaces or changes existing debt; recapitalization changes the mix of debt and stock. No option has been selected, so the review is not a signed deal.

Stem Review Has No Set Timetable

Stem gave no timetable and said the review may not produce a transaction. It also said it would not share further developments unless the board approves a deal or disclosure is required. The possible outcome remains unsettled, rather than a transaction shareholders can evaluate.

Quick Financial Overview

Stem is a micro-cap, meaning a very small public company, with real revenue but a net loss. Its market value, the worth of all its shares, is $25.1M. Its latest report showed $38.4M in cash and cash equivalents, meaning cash the company can spend, as of June 30, 2026.

Stem Revenue and Earnings

Stem reported revenue of $33.7M and a net loss of $14.4M in its latest quarter. The loss shows that sales did not cover all costs.

Stem Float and Trading Volume

Trading totaled about 740,000 shares, about five times the normal pace. Stem’s float, meaning shares available for public trading, is about 9.1 million shares. That activity against a relatively small pool can magnify swings, but volume alone does not show which side led.

Stem Stock Is down 88% Over The Past Year

Stem traded around $4.50 a month ago and has continued lower. Today, shares ranged from around $2.25 to a high near $3.00, with the high coming this morning.

Stem New York Stock Exchange Notice

Before the strategic review, Stem disclosed it did not meet the New York Stock Exchange’s continued-listing standards, the rules for keeping shares listed. The company said its shares could keep trading while it worked on a plan to regain compliance, subject to exchange requirements. That earlier notice adds pressure to the backdrop, but it was not today’s new development.

Stem Third-Quarter Earnings Date

Stem plans to report third-quarter results after the close on Thursday, November 5, 2026, followed by a conference call. The report will give holders a fresh look at the business while the board’s review remains unresolved.

Conclusion

The coming quarterly report will show whether Stem is making progress as the board weighs its options. Better sales and smaller losses could support staying independent, while weaker results could make a sale or financing change more important.